ArticleBMC complementary medicine and therapies2026

Umbelliprenin co-formulated with selenium nanoparticles downregulates MMP-2, MMP-9 and ICAM-1 expression in triple-negative breast cancer cells MDA-MB-231.

Farnaz Azimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.